FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280614882> ?p ?o ?g. }

• W4280614882 endingPage "S31" @default.
• W4280614882 startingPage "S31" @default.
• W4280614882 abstract "Tramadol is a commonly used analgesic worldwide to control moderate to severe pain. There has been growing evidence of hypoglycemia with tramadol use, yet hypoglycemia seems to be an underappreciated side effect by many physicians. Even though the percentage of hypoglycemia from tramadol is 1%- 5%, it is a life-threatening side effect. We are presenting this case report to increase awareness of the dangerous side effects of tramadol use. An 86 year old man with a history of coronary artery disease, valve replacement, pacemaker, hypertension, hypercholesterolemia, and diverticulitis with colon resection required EMS attention due to loss of consciousness. His medications included aspirin, atorvastatin, labetalol, losartan, hydrochlorothiazide, warfarin, and tramadol. A point of care (POC) glucose measurement by EMS was 17 mg/dL. After 250 ml of 10% dextrose, he regained consciousness. In the ED, a laboratory blood glucose level was 45 mg/dL. Simultaneous insulin and c-peptide levels were 9.4 mU/mL and 5.7 ng/mL, respectively. Abdominal CT was negative for pancreatic, liver, or retroperitoneal mass. Tramadol was discontinued and he was discharged home after 3 days of observation. There were no further episodes of hypoglycemia. A 24 hour fast was performed in the outpatient setting, during which time hypoglycemia did not occur. Pill identification revealed no antihyperglycemic medications. Laboratory testing at the end of the fast: glucose 88 mg/dL, insulin 2.3 mU/mL, c-peptide 0.75 ng/mL, proinsulin 4.3 pmol/L, and diabetes medication screen was negative. At follow-up 3 months later, no other episodes of hypoglycemia have occurred. Various mechanisms of tramadol induced hypoglycemia have been proposed, including increased insulin sensitivity, mu opioid receptor activation causing a reduction in hepatic gluconeogenesis, and increased utilization of glucose in peripheral tissue. A retrospective study describes a strong association of hypoglycemia with use of tramadol or methadone monotherapy. There have been cases reported in the setting of critically ill patients where tramadol use caused more agitation and restlessness in patients after 60-90 minutes after intravenous tramadol use. This poses an increased risk as symptoms of hypoglycemia would be difficult to identify in the critical care setting. This case illustrates that hypoglycemia can be a presenting symptom with tramadol use in patients with no prior history of diabetes, who are not on any glucose lowering agent. It is critical to recognize hypoglycemia in tramadol treated patients early to promptly initiate treatment." @default.
• W4280614882 created "2022-05-22" @default.
• W4280614882 creator A5045194437 @default.
• W4280614882 creator A5054159896 @default.
• W4280614882 date "2022-05-01" @default.
• W4280614882 modified "2023-09-26" @default.
• W4280614882 title "Abstract #1177061: Life-threatening hypoglycemia in a non-diabetic patient on Tramadol" @default.
• W4280614882 doi "https://doi.org/10.1016/j.eprac.2022.03.087" @default.
• W4280614882 hasPublicationYear "2022" @default.
• W4280614882 type Work @default.
• W4280614882 citedByCount "1" @default.
• W4280614882 countsByYear W42806148822022 @default.
• W4280614882 crossrefType "journal-article" @default.
• W4280614882 hasAuthorship W4280614882A5045194437 @default.
• W4280614882 hasAuthorship W4280614882A5054159896 @default.
• W4280614882 hasBestOaLocation W42806148821 @default.
• W4280614882 hasConcept C126322002 @default.
• W4280614882 hasConcept C134018914 @default.
• W4280614882 hasConcept C2776307423 @default.
• W4280614882 hasConcept C2777180221 @default.
• W4280614882 hasConcept C2778213512 @default.
• W4280614882 hasConcept C2779306644 @default.
• W4280614882 hasConcept C2779777798 @default.
• W4280614882 hasConcept C2780668416 @default.
• W4280614882 hasConcept C2780820201 @default.
• W4280614882 hasConcept C42219234 @default.
• W4280614882 hasConcept C555293320 @default.
• W4280614882 hasConcept C71924100 @default.
• W4280614882 hasConceptScore W4280614882C126322002 @default.
• W4280614882 hasConceptScore W4280614882C134018914 @default.
• W4280614882 hasConceptScore W4280614882C2776307423 @default.
• W4280614882 hasConceptScore W4280614882C2777180221 @default.
• W4280614882 hasConceptScore W4280614882C2778213512 @default.
• W4280614882 hasConceptScore W4280614882C2779306644 @default.
• W4280614882 hasConceptScore W4280614882C2779777798 @default.
• W4280614882 hasConceptScore W4280614882C2780668416 @default.
• W4280614882 hasConceptScore W4280614882C2780820201 @default.
• W4280614882 hasConceptScore W4280614882C42219234 @default.
• W4280614882 hasConceptScore W4280614882C555293320 @default.
• W4280614882 hasConceptScore W4280614882C71924100 @default.
• W4280614882 hasIssue "5" @default.
• W4280614882 hasLocation W42806148821 @default.
• W4280614882 hasOpenAccess W4280614882 @default.
• W4280614882 hasPrimaryLocation W42806148821 @default.
• W4280614882 hasRelatedWork W2004263509 @default.
• W4280614882 hasRelatedWork W2026120080 @default.
• W4280614882 hasRelatedWork W2068655959 @default.
• W4280614882 hasRelatedWork W2278543854 @default.
• W4280614882 hasRelatedWork W2315092269 @default.
• W4280614882 hasRelatedWork W2376237852 @default.
• W4280614882 hasRelatedWork W2389999617 @default.
• W4280614882 hasRelatedWork W2431101004 @default.
• W4280614882 hasRelatedWork W2794438779 @default.
• W4280614882 hasRelatedWork W65680645 @default.
• W4280614882 hasVolume "28" @default.
• W4280614882 isParatext "false" @default.
• W4280614882 isRetracted "false" @default.
• W4280614882 workType "article" @default.